- This event has passed.
Ovarian Cancer Screening: More than a Pelvic Exam
September 7, 2022 @ 12:00 pm - 12:45 pm EDT
In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.
Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women.
SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events will discuss how to improve health outcomes for diseases and conditions that disproportionately or exclusively affect women, with special a focus on cancers, reproductive health, and bone health.
The SWHR Value of Diagnostics within Women’s Health series includes:
- How Vaccines and Screening Can Prevent Cervical Cancer (January 26, 2022)
- Improving Lives by Detecting Sexually Transmitted Infections Early (April 13, 2022)
- Assessing and Promoting Bone Health Across the Lifespan (May 18, 2022)
- How Hormones Can Tell a Fertility Story (June 8, 2022)
- Ovarian Cancer Screening: More than a Pelvic Exam (September 7, 2022)
- Understanding the Tests that Could Save My Breasts (October 12, 2022)
Goals
- Discuss the impacts of ovarian cancer on women’s health, including disparities in disease burden and access to care
- Provide an overview of screening guidelines and diagnostic tests for patients and key considerations for disease management
- Emphasize ways to empower women and improve quality of care and gynecologic health and wellbeing
Panelists
Barbara Goff, MD
Barbara Goff, MD
Dr. Barbara Goff received her MD from the University of Pennsylvania and completed her residency in Obstetrics and Gynecology at Brigham and Women’s Hospital. She then completed a fellowship in Gynecologic Oncology at Massachusetts General Hospital. Dr. Goff joined the faculty at the University of Washington in 1993 and was the Director of the Division of Gynecologic Oncology from 2005 to 2017. In August 2015 she was appointed Surgeon-in-Chief for the University of Washington Medical Center and in 2017 was appointed the Chair of the Department of Obstetrics and Gynecology where she leads a group of over 150 clinicians and scientists.
Dr. Goff has authored more than 150 articles and has written multiple textbook chapters on gynecologic malignancies. Her primary research interests have been evaluating novel markers for early detection of ovarian cancer and clinical trials for novel therapeutics in treatment of ovarian cancer. She specializes in surgical treatment of gynecologic malignancies, robotic surgery, chemotherapy for gynecologic cancers, clinical trials and early detection of ovarian cancer.
Dineo Khabele, MD
Dineo Khabele, MD
Dineo Khabele, MD is the Mitchell & Elaine Yanow Professor and Chair of the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Louis. She is a recognized physician-scientist with extensive clinical and translational research experience in gynecologic oncology, with a focus on ovarian cancer. Dr. Khabele’s ovarian cancer research is funded by the National Institutes of Health (NIH)/National Cancer Institute (NCI). Her ovarian cancer research interests include chemotherapy resistance, DNA repair, epigenetic targets for therapy, and targeting the tumor microenvironment. She is a dedicated educator and mentor to students, residents, fellows, and faculty. She is an advocate for women’s health, women’s cancers, and health equity.
Dr. Khabele is board certified in Obstetrics and Gynecology and Gynecologic Oncology and obtained undergraduate and medical degrees from Columbia College and Columbia College of Physicians and Surgeons of Columbia University in New York. She completed her residency in obstetrics and gynecology at The New York Presbyterian Hospital, Weill-Cornell University Medical Center, followed by a clinical fellowship in gynecologic oncology and post-doctoral research training in cancer biology at Albert Einstein College of Medicine and Montefiore Medical Center. She was a scholar of the Reproductive Scientist Development Program and the Amos Medical Faculty Development Program Scholar/Robert Wood Johnson Foundation.
Sponsor
SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.
